¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"phase evolution of fat suppression"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fat
    Áö¹æ
  • fat atrophy
    Áö¹æÀ§Ãà
  • fat blood level
    Áö¹æÇ÷Ãþ
  • fat cell
    Áö¹æ¼¼Æ÷
  • fat deficiency disease
    Áö¹æ°áÇ̺´
  • fat depot
    ÀúÀåÁö¹æ
  • fat embolism
    Áö¹æ»öÀüÁõ
  • fat metabolism
    Áö¹æ´ë»ç
  • fat necrosis
    Áö¹æ±«»ç
  • fat pad sign
    Áö¹æÆÐµå¡ÈÄ
  • fat-free body mass
    Áö¹æÁ¦¿ÜüÁß
  • fat-soluble
    Áö¿ë¼º-
  • fat-storing cell
    Áö¹æÀúÀå¼¼Æ÷
  • fascia-fat flap
    ±Ù¸·Áö¹æÇÇÆÇ
  • hypodermic fat
    ÇǺιØÁö¹æ, ÇÇÇÏÁö¹æ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • active phase
    Ȱ¼º±â
  • latent phase
    ÀáÀç±â , Àẹ±â
  • plateau phase
    ÆíÆò±â, °íÁ¶±â
  • relaxation phase
    À̿ϱâ, À̿ϻó
  • resolution phase
    ÇØ¼Ò±â
  • resting phase
    È޽ıâ
  • solid phase
    °íü»ó
  • stance phase
    µðµõ±â, ÀÔ°¢±â
  • swing phase
    Èçµê±â, À¯°¢±â
  • synaptic phase
    ¿¬Á¢±â
  • expiratory phase time
    ³¯¼û½Ã°£, È£±â½Ã°£
  • inspiratory phase time
    µé¼û½Ã°£, Èí±â½Ã°£
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • water suppression
    ¹°ºÐÀÚ¾ïÁ¦
  • fat atrophy
    Áö¹æÀ§Ãà
  • body fat
    ¸öÁö¹æ, üÁö¹æ
  • buccal fat pad
    º¼Áö¹æµ¢ÀÌ
  • buccal fat pad excision
    º¼Áö¹æÃ¼ÀýÁ¦¼ú
  • fat cell
    Áö¹æ¼¼Æ÷
  • fat-storing cell
    Áö¹æÀúÀå¼¼Æ÷
  • depot fat
    ÀúÀåÁö¹æ
  • fat deficiency disease
    Áö¹æ°áÇÌÁõ
  • mutton fat deposit
    ±»±â¸§Ä§Âø¹°
  • elbow fat pad sign
    ÆÈ²ÞÄ¡Áö¹æÆÐµå¡ÈÄ
  • fat embolism
    Áö¹æ»öÀüÁõ
  • fat
    Áö¹æ
  • fat-soluble
    Áö¿ë¼º-
  • fascia-fat flap
    ±Ù¸·Áö¹æÇÇÆÇ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Go phase
    Go±â
  • accelerated death phase
    °¡¼Ó»ç¸ê±â(˧ËÛË×ËÎË»).
  • acceleration phase
    ÃËÁø±â, °¡¼Ó±â(Ê¥áÜÑ¢).
  • acute phase protein
    ±Þ¼ºº´±â´Ü¹éÁú
  • acute phase reactant
    ±Þ¼º±â ÀÛ¿ë¹°Áú
  • acute phase reaction
    ±Þ¼º±â¹ÝÀÀ(¡­Ñ¢Úãëë)
  • acute phase reactive protein
    ±Þ¼º±â ¹ÝÀÀ¼º ´Ü¹é.
  • acute phase serum
    ±Þ¼ºº´±âÇ÷û
  • acute phase substances
    ±Þ¼º±â ¹°Áú(ÐáàõÑ¢Úªòõ).
  • advanced sleep phase syndrome
    ÀüÁø¼º ¼ö¸éÀ§»ó ÁõÈıº
  • anal-sadistic phase
    Ç×¹®-°¡ÇÐ(½Ã)±â
  • arterial phase
    µ¿¸Æ±â
  • full erection phase
    ¿ÏÀü¹ß±â±â
  • g0 phase
    Á¤Áö±â G0±â
  • g1 phase
    ÇÕ¼ºÀü±â G1±â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • anti-suppression exercise
    ¾ïÁ¦¹æÁöÈÆ·Ã
  • burst suppression
    °¨Á¤¾ï¾Ð
  • central suppression
    Á߽ɾïÁ¦
  • deoxyuridine suppression test
    µ¥¿Á½Ã¿ì¸®µò¾ïÁ¦½ÃÇè
  • dexamethasone suppression test
    µ¦»ç¸ÞŸÁ¸¾ïÁ¦½ÃÇè
  • dust suppression
    ¸ÕÁö¹ß»ý¾ïÁ¦.
  • facultative suppression
    ÀӽþïÁ¦
  • glucocorticoid suppression test
    ´çÁúÄÚ¸£Æ¼ÄÚÀ̵å¾ïÁ¦½ÃÇè.
  • immune response suppression
    ¸é¿ª¹ÝÀÀ¾ïÁ¦<--¾ï¾Ð>
  • magnetization transfer suppression
    ÀÚÈ­ Àü´Þ ¾ïÁ¦
  • motion artifact suppression technique
    ¿îµ¿ Àΰø À½¿µ ¾ïÁ¦¼ú
  • obligatory suppression
    ºÒº¯¾ïÁ¦
  • phenotypic suppression
    Ç¥ÇöÇü ¾ïÁ¦
  • suppression
    ¾ïÁ¦(åäð¤).
  • suppression amblyopia
    ¾ïÁ¦¾à½Ã (¡­å°ãÊ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Bilateral phase
    ´ëαâ
    [¿¾ ¿ë¾î] ¾çÃø»ó
  • Phase of desquamation
    ¹Ú¸®±â
    [¿¾ ¿ë¾î] ¹Ú¸®±â
  • Phase of incornification
    ºñ°¢Áú±â
    [¿¾ ¿ë¾î] ºñ°¢ÁúÈ­±â
  • Unequal phase
    ºñ´ëαâ
    [¿¾ ¿ë¾î] ºÎµî»ó
  • Inactive phase
    ºñȰµ¿±â
    [¿¾ ¿ë¾î] ÈÞÁö±â
  • Lactiferous phase
    ¼öÀ¯±â
    [¿¾ ¿ë¾î] ¼öÀ¯±â
  • Synaptic phase
    ¿¬Á¢±â
    [¿¾ ¿ë¾î] ¿¬Á¢±â
  • Menstrual phase
    ¿ù°æ±â
    [¿¾ ¿ë¾î] ¿ù°æ±â
  • Postmenstrual phase
    ¿ù°æÈıâ
    [¿¾ ¿ë¾î] ¿ù°æÈıâ
  • Zygotene phase
    Á¢ÇÕ±â
    [¿¾ ¿ë¾î] Á¢ÇÕ±â
  • Go phase
    Á¤Áö±â [Go±â]
    [¿¾ ¿ë¾î] Á¤Áö±â
  • Proliferative phase
    Áõ½Ä±â
    [¿¾ ¿ë¾î] Áõ½Ä±â
  • Implantational phase
    Âø»ó±â
    [¿¾ ¿ë¾î] Âø»ó±â
  • Preimplantational phase
    Âø»óÀü±â
    [¿¾ ¿ë¾î] Âø»óÀü±â
  • Colostral phase
    ÃÊÀ¯±â
    [¿¾ ¿ë¾î] ÃÊÀ¯±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Darwinian evolution
    ´ÙÀ© ÁøÈ­(òäûù)
  • divergent evolution
    ºÐÁö ÁøÈ­(ÝÂò«òäûù)
  • evolution
    ÁøÈ­(òäûù)
  • evolution theory
    ÁøÈ­·Ð(òäûùÖå)
  • horizontal evolution
    ¼öÆò ÁøÈ­(â©øÁòäûù)
  • molecular evolution
    ºÐÀÚÁøÈ­(ÝÂí­òäûù)
  • neutral theory of molecular evolution
    Á߸³ºÐÀÚÁøÈ­·Ð(ñ騡ÝÂí­òäûùÖå)
  • protein evolution
    ´Ü¹éÁú ÁøÈ­(Ó±ÛÜòõòäûù)
  • vertical evolution
    ¼öÁ÷ ÁøÈ­ (á÷òÁòäûù)
  • allotype suppression
    µ¿Á¾ÀÌÇü¾ï¾Ð(ÔÒðúì¶úþåääâ)
  • external suppression
    ¿ÜºÎ ¾ï¾Ð(èâÝ»åääâ)
  • extracistronic suppression
    ½Ã½ºÆ®·Ð¿Ü(èâ) ¾ï¾Ð(åääâ)
  • extragenic suppression
    ¿Ü·¡ ¾ï¾Ð (èâÕÎåääâ)
  • frameshift suppression
    ƲÀ̵¿(ì¹ÔÑ) ¾ï¾Ð(åääâ)
  • idiotype suppression
    °³Ã¼Æ¯ÀÌÇü ¾ï¾Ð(ËÁô÷÷åì¶úþåääâ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fat meal
    Áö¹æ½Ä
  • fat pad sign
    Áö¹æÆÐµå¡ÈÄ
  • fat plane
    Áö¹æ¸é
  • fat saturation pulse
    Áö¹æÆ÷È­ÆÞ½º
  • subcutaneous fat
    ÇÇÇÏÁö¹æ
  • 3D phase contrast angiography
    3Â÷¿øÀ§»ó´ëÁ¶ Ç÷°üÃÔ¿µ¼ú
  • arterial phase
    µ¿¸Æ±â
  • bulk phase model
    µ¢¾î¸®À§»ó¸ðÇü
  • equilibrium phase
    ÆòÇü±â
  • gradient induced phase shift effect
    °æ»çÀ¯µµ À§»óº¯À§È¿°ú
  • in phase
    µ¿À§»ó
  • in-phase image
    À§»ó³»¿µ»ó
  • intravoxel phase dispersion
    º¹¼¿³»À§»óÈ®»ê
  • out of phase
    Å»À§»óÀÇ
  • out of phase gradient echo image
    Å»À§»ó°æ»ç¿¡ÄÚ¿µ»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
SPIA solid-phase immunoabsorption; solid-phase immunoassay
DST   1) Donor Specific Transfusion
  2) Dexamethasone Suppression Test
CAST calpastatin; Cardiac Arrhythmia Suppression Trial; Children of Alcoholism Screening Test
DST desensitization test; dexamethasone suppression test; dihydrostreptomycin; disproportionate septal t...
HTS head traumatic syndrome; HeLa tumor suppression; human thyroid-stimulating hormone, human thyroid st...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CISS Chromosomal in situ suppression
CSD Conditioned Suppression of Drinking
DSI Depolarisation-induced suppression of inhibition
DST Dexamethasone Suppression Test
IS Immune suppression
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fat degeneration
    Áö¹æ º¯¼º
  • fat embolism syndrome
    Áö¹æ »öÀü ÁõÈıº
    Áö¹æ ¼ººÐÀÌ ´ëºÎºÐÀΠȲ»ö °ñ¼ö·Î µÈ °ñÀÇ °ñÀý ¶Ç´Â Áö¹æ Á¶Á÷ÀÇ ½ÉÇÑ ¿Ü»ó ÈÄ¿¡ Á¡ÁøÀû Æó ºÎÀüÁõ, Á¤½Å·Â ÀúÇÏ¿Í ½Å ºÎÀüÁõÀ» ÃÊ·¡ÇÏ´Â °ÍÀ» ¸»ÇÑ´Ù. ÀÌ´Â ÆÄ¿­µÈ Ç÷°ü ¼ÓÀ¸·Î ¹«¼öÇÑ Áö¹æ±¸°¡ µé¾î°¡ ¿©·¯ Àå±â¿¡ ºÐÆ÷ÇÑ Ç÷°ü¿¡ »öÀüÁõÀ» ¾ß±âÇÔÀ¸·Î½á ÀϾ´Ù. ÀϹÝÀûÀ¸·Î º´ÀηÐÀº º¹ÇÕÀûÀÌ´Ù. ÀÏ´Ü ÀÌ ÁõÈıºÀÌ ¹ß»ýÇÏ¸é ¸Å¿ì À§µ¶ÇÏ¿© ´ë·« 10-15%ÀÇ »ç¸Á·üÀ» ³ªÅ¸³½´Ù.
  • fat graft
    Áö¹æ ÀÌ½ÄÆí, Áö¹æ À̽Ä
    ÁöÁö Á¶Á÷¿¡¼­ ¿ÏÀüÈ÷ À¯¸®½ÃŲ Áö¹æÀÇ À̽Ä. ÇÔ¸ôºÎ¸¦ ¸Þ¿ì±â À§ÇØ »ç¿ëÇÑ´Ù.
  • fat infiltration
    Áö¹æ ħÀ±
  • fat necrosis
    Áö¹æ ±«»ç
  • fat plane
    Áö¹æ ¸é
  • fat soluble
    Áö¿ë¼ºÀÇ
  • hypodermic fat
    ÇÇÇÏ Áö¹æ
    ÇÇÇÏ Á¶Á÷¿¡ Á¸ÀçÇÏ´Â Áö¹æÃþ.
  • multilocular fat cell
    ¹µÄ­ Áö¹æ ¼¼Æ÷
  • pararenal fat pad
    ÄáÆÏ ÁÖÀ§ Áö¹æÃ¼
  • perirenal fat
    ½Å ÁÖÀ§ Áö¹æ
  • polyunsaturated fat
    ´ÙºÒÆ÷È­ Áö¹æ
    carbon chain¿¡¼­ ÇÑ °³ ÀÌ»óÀÇ ÀÌÁß °áÇÕÀ» °®°í ÀÖ´Â Áö¹æ»êÀ» ÇÔÀ¯ÇÏ´Â Áö¹æ.
  • serum neutral fat
    Ç÷û Áß¼º Áö¹æ
    Ç÷û Áß¼º Áö¹æÀº ´ëºÎºÐÀÌ Æ®¸®±Û¸®¼¼¶óÀ̵åÀ̰í, ±× ³óµµ´Â À½½Ä¹°ÀÇ ¿µÇâÀ» ¹Þ´Â´Ù.
  • traumatic fat necrosis
    ¿Ü»ó¼º Áö¹æ ±«»ç
  • traumatric fat necrosis
    ¿Ü»ó¼º Áö¹æ ±«»ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
coincidental evolution <molecular biology> The tendency for the same mutation to arise simultaneously in all copies of a gene which has been duplicated.
(09 Oct 1997)
concerted evolution The ability of two related genes to evolve together as though constituting a single locus.
Synonym: coincidental evolution.
(05 Mar 2000)
convergent evolution The process where two unrelated structures in unrelated organisms evolve to perform similar functions. (The structures are called analogous structures.) For example: the wings of bats, birds, and insects evolved separately from each other but all are used to perform the function of flying. For another example: the complex eyes of vertebrates, cephalopods (squid and octopus), cubozoan jellyfish, and arthropods (insects, spiders, crustaceans) evolved separately, but all perform the function of vision.
(09 Oct 1997)
cultural evolution The continuous developmental process of a culture from simple to complex forms and from homogeneous to heterogeneous qualities.
(12 Dec 1998)
saltatory evolution The theory that evolution of a new species from an older one may occur as a large jump, such as a major repatterning of chromosomes, rather than by gradual accumulation of small steps or mutations.
Compare: emergent evolution.
(05 Mar 2000)
spontaneous evolution The unaided delivery of the foetus from a transverse lie.
(05 Mar 2000)
Darwinian evolution The proposition that the phylogeny of all species is wholly ascribable to the combined effects of random variation (mutation) in genotypes of the members of a stock as a result of the operation of undirected accidents with consequences to their phenotypes and the operation of preferential (but by no means certain) survival of those resulting phenotypes most suited to survive in the contemporary environment. The proposed system survives largely because of genetic factors that avidly conserve the ontogeny of the stock.
(05 Mar 2000)
Denman's spontaneous evolution A mechanism of spontaneous molding of the foetus and impaction of the shoulder with prolapse of the arm noted in some cases of transverse lie; vaginal delivery is achieved with the breech appearing at the vulva immediately after the prolapsed shoulder.
(05 Mar 2000)
directed molecular evolution Techniques used to produce molecules exhibiting properties that conform to the demands of the experimenter.
(12 Dec 1998)
divergent evolution The process by which a species or gene product gives rise to two or more different products.
(05 Mar 2000)
Douglas' spontaneous evolution A mechanism whereby molding of the foetus and impaction of the shoulder and prolapsed arm occurs in transverse lie, allowing vaginal delivery with the lateral aspect of the thorax following the prolapsed shoulder.
(05 Mar 2000)
quantum evolution An extremely rapid evolutionarychange in a single genetic lineage, thought to result from a sudden and radical change in the species'environment.
(09 Oct 1997)
organic evolution Biologic evolution was contrasted with cultural evolution in 1968 by A.G. Motulsky who pointed out that biologic evolution is mediated by genes, shows a slow rate of change, employs random variation (mutations) and selection as agents of change, new variants are often harmful, these new variants are transmitted from parents to offspring, the mode of transmission is simple, complexity is achieved by the rare formation of new genes by chromosome duplication, biologic evolution occurs with all forms of life, and the biology of humans requires cultural evolution. See Cultural evolution.
(12 Dec 1998)
emergent evolution Appearance of a property in a complex system e.g., organism that could have been predicted only with difficulty, or perhaps not at all, from a knowledge and understanding of the individual genotype changes taken separately.
(05 Mar 2000)
evolution 1. An unrolling.
2. A process of development in which an organ or organism becomes more and more complex by the differentiation of its parts, a continuous and progressive change according to certain laws and by means of resident forces.
Origin: L. Evolutio
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fat cat
    Á¤Ä¡ ÀÚ±ÝÀ» ¸¹ÀÌ ¹ÙÄ¡´Â ºÎÀÚ;¼¼·Â°¡;À¯¸íÀÎ;µ· ¸¹Àº Ư±ÇÀÎ
  • fat city
    ´õÇÒ ¼ö ¾øÀÌ ÁÁÀº »óÅÂ(»óȲ,Àü¸Á)
  • fat farm
    =health spa
  • fat farm
    »ì»©´Â µµÀå
  • fat lamb
    ºñÀ° »õ³¢¾ç
  • fat lime
    ºÎ¼®È¸
  • green fat
    ¹Ù´Ù°ÅºÏÀÇ ±â¸§(Áø¹Ì)
  • puppy fat
    (À¯¾Æ±â,»çÃá±âÀÇ ÀϽÃÀû) ºñ¸¸
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á